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ABSTRACT
A STUDY ON ROLE OF URINE TRYPSINOGEN-2 IN DIAGNOSING
ACUTE PANCREATITIS
Introduction
Acute pancreatitis is a very common disorder, with substantial burden on the
healthcare system1. Acute pancreatitis includes wide spectrum of disease varying
from mild self-limiting symptoms to fulminant multi organ failure and high
mortality. Serum amylase and serum lipase which are used for the diagnosis of
acute pancreatitis are relatively less sensitive and specific and gives a lot of false
positive or false negative values. The urinary trypsinogen-2 dipstick test,  proposed
to be a rapid  method for the  diagnosis of acute pancreatitis at the earliest, based
on the immune-chromatographic method.
Materials and Methodology
? 100 Patients presenting with  acute upper abdominal symptoms like pain,
vomiting, abdominal distention, admitted in the emergency department of
our hospital from January 2013 to November 2013 are enrolled in the study.
? Urine sample were obtained from all the patients and tested with  Spot Urine
trypsinogen-2 dipstick.
? Serum amylase and serum lipase  tests were also simultaneously done in
these patients. Patients are also evaluated with  (USG) abdomen and (CECT)
abdomen ,if required.
? Final diagnosis of acute pancreatitis is made on the basis of clinical picture,
serum amylase more than threefold rise and radiological findings.
?  Urine trypsinogen-2 dipstick test  were compared with serum amylase,
serum lipase and imaging studies in patients with final diagnosis of acute
pancreatitis
Results
Sensitivity of amylase and lipase was found to be 73.77% and  59.02%
respectively, whereas as sensitivity of trypsinogen was found to be 78.69%.
Specificity of amylase and lipase was found to be 89.74% and 89.74%
respectively, whereas as specificity of trypsinogen was found to be
92.1%.Analysing the data ,it is found that sensitivity and specificity of trypsinogen
is higher than the routine investigations. Eventhough it has a low range of
sensitivity, its high specificity ensures that the test can be used as a screening test
to check the true negative cases.
Conclusion
1. Urine Trypsinogen-2  dip stick test is a simple, rapid, easy, and noninvasive
test which can diagnose or rule out, most of the cases of acute pancreatitis.
2. Urine Trypsinogen-2 estimation doesn't require laboratory facilities. It is
undertaken almost instantaneously (within 5 minutes) as opposed to serum
amylase and lipase, results for which may require an hour to get back to the
physician.
3.  The urinary trypsinogen-2 test could  be used as a screening test for acute
pancreatitis.
4.  Modification of the cutoff point of this assay increases the specificity to the
point where it can be used for diagnosis.
 Qualitative rapid urine trypsinogen-2 test strip is easy to perform. And
hence it has  been shown to be a reliable and useful screening test for acute
pancreatitis in daily practice
[12-16], particularly in healthcare units lacking laboratory facilities.
Keywords
Acute Pancreatitis, Serum Amylase, Serum Lipase, Urine Trypsinogen-2.
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INTRODUCTION 
Acute pancreatitis is a very common disorder, with substantial 
burden on the healthcare system1. Acute pancreatitis includes wide 
spectrum of disease varying from mild self-limiting symptoms to 
fulminant multi organ failure and high mortality. The overall mortality 
rate is 3-10%, wherein 11-30% of cases are with severe disease 
manifested as pancreatic necrosis. 
Since 1974, several scoring systems have been developed 
clinically and radiologically assessing the prognosis of the disease. The 
rationale behind the assessment of severity is mainly for practical 
purpose, where mild pancreatitis needs supportive care but severe 
pancreatitis needs intensive monitoring  and it has a guarded prognosis. 
The key to reduce the mortality and morbidity of the disease is 
early detection and appropriate management. An ideal diagnostic 
method should be able to differentiate between patients with mild & 
severe disease, easy usability,  widely available and should be accurate, 
and  with low inter-observer variability. It should  be able to detect early 
disease ,so that patient before developing  potential complications,could 
be  monitored and treated, if possible empirically. 
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Serum amylase and serum lipase which are used for the diagnosis 
of acute pancreatitis are relatively less sensitive and specific and gives a 
lot of false positive or false negative values. Various scoring systems are 
being used in acute pancreatitis to predict the severity and outcome of 
the disease. There is no single comprehensive test to aid in early and 
accurate detection of acute pancreatitis. 
The urinary trypsinogen-2 dipstick test,  proposed to be a rapid  
method for the  diagnosis of acute pancreatitis at the earliest, based on 
the immune-chromatographic method.  
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REVIEW OF LITERATURE 
HISTORY OF THE PANCREAS 
• Herophilus, a Greek anatomist cum surgeon, first discovered the 
pancreas, in 336 BC ,on the Asiatic side of the Bosporus, 
Chalcedon2.  
• The word pancreas first mentioned in the writings of Eristratos 
(310-250 B.C.). Then Four hundred years later, Rufus, an 
anatomist cum surgeon of Ephesus, termed the name “pancreas”. 
Written in Greek , the word quotes “pan: all, kreas: flesh”2. 
• Galen (138-201 AD)a Romen physician, and “Physician to the 
Gladiators”, said that the pancreas serves as a cushion, protecting  
the large blood vessels, lying behind it2. 
• In March 2, 1642, Johann Georg Wirsüng, a German, 
discovered the pancreatic duct, at San Francisco Monastery, 
Padua, Italy. But it was named by his colleague as “The Duct of 
Wirsüng”2. The duct  enlarges at the terminal point as the papilla, 
which projects into the second part of duodenum, was first 
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described by Vater in 1720. In 1734,Santorini, described the 
accessory duct,that bears his name. 
• In 1869, Paul Langerhans (“Junior”), a student of -the famous 
Berlin Institute of Pathology, headed by the eminent Professor, 
Rudolph Virchow, described the pancreatic islets2,which  was 
the first  histologic description of the pancreas. 
• In 1893, Laguesse suggested that the islet cells produce a 
hormone. In 1909 Jean de Meyer suggested the name 'insulin' for 
this hormone. 
• Eugene Lindsay Opie (1873-1971) was able to show the 
association between diabetes and failure of the islet cells and in 
1901, proposed his "common channel" hypothesis3. 
• In 1908, Julius Wohlgemuth, Berlin, devised a method to 
measure the serum amylase concentration (“diastase”), which was 
found to be  useful in diagnosing  acute pancreatitis, prior to 
laparotomy or autopsy2. 
• Since 1898, many surgeons undertook various steps for the 
resection of tumors of ampulla and head of the pancreas. Allen O. 
Whipple (1881-1963), son of American missionaries, Persia, was 
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recognized as the “Father of Pancreatic Surgery” for his 
successful single stage surgery in pancreatic head tumors2. 
• In 1963, the first Marseilles Symposium favored the development 
of classification system for pancreatitis. This was revised in 1984; 
at the second Marseilles Symposium. 
• Finally, at the Atlanta Symposium, in 1992, clinically oriented 
classification system was established for acute pancreatitis. 
• Although the disease now classified as acute pancreatitis has been 
known from antiquity, it is only at mid-19th century, the 
importance of pancreas and its severity became evident. In 1889, 
Fitz presented the clinical and pathology of acute pancreatitis. 
Moynihan in 1925 described "the most terrible of all the 
calamities which occur in relation with the abdominal viscera" as 
acute pancreatitis4, 5.  
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Gross Anatomy 
The pancreas, a retroperitoneal organ , extends from the C-loop of 
the duodenum to the splenic hilum in a oblique manner 7. 
The pancreas lies behind  the stomach, roughly in the Trans 
pyloric plane. The gland weighs approximately 80gm, varying from  
75 – 125gm and measures 15 to 22 cm length in adults7. 
The pancreas has four parts7, 8: 
• The head including  the uncinate process,  
• The neck,  
• The body and 
• The tail. 
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The head lies within the duodenal C- loop .It overlies the  second 
lumbar vertebral body and the inferior vena cava(IVC), with the aorta 
lying beneath the neck of the gland. The right renal artery and the renal 
veins lie posteriorly behind  the head of the pancreas. Coming off ,the 
side of the head of pancreas, and passing to the left , is the pancreatic 
uncinate process.  
The neck of pancreas lies  anterior to the portal vein. Behind the 
pancreatic neck , the superior mesenteric vein and the splenic vein join 
to form the portal vein. The inferior mesenteric vein(IMV) forms the  
tributary of   the splenic vein. Sometimes, the  IMV drains into the SMV 
or  with the superior mesenteric-portal venous junction, forming  a 
trifurcation. The common bile duct(CBD) lies within a groove in the 
head of the pancreas, until joining the main pancreatic duct. Both the 
ducts, join to form the  ampulla of Vater, opening  into the 2nd part of 
the duodenum. 
The pancreatic body and tail  lies anterior to the splenic artery and 
its vein. The splenic vein lies in a groove, draining multiple  pancreatic 
venous branches. These venous branches  must be ligated to perform a 
spleen-sparing distal pancreatectomy. Along the postero superior edge 
of the pancreatic body and tail, lies the splenic artery , parallel to the 
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vein. The splenic artery is highly  tortuous. The  pancreatic body is 
covered by the peritoneum, the gastrocolic omentum. On dividing the 
gastrocolic omentum ,the body and tail of the pancreas can be visualized 
at the floor of the lesser sac, just posterior to the stomach. It is in this 
area pancreatic pseudocysts commonly develop , in relation to the 
posterior aspect of the stomach , allowing drainage of  the cyst to  the 
stomach. The transverse mesocolon  base ,attaches to the inferior margin 
of the body and tail of pancreas. 
The body of pancreas overlies the aorta, near the origin of the 
superior mesenteric artery.  Blunt antero-posterior trauma can compress 
the neck of the pancreas against the spine of L1 and L2, causing  injury 
to the pancreatic parenchyma and the  duct.  
Pancreatic Ductal Anatomy: 
Pancreatic duct anatomy and its variations  can be understood  by 
knowing the embryology of pancreas. It  is formed by the fusion of a 
ventral bud and a dorsal bud9.  
• The duct from the smaller ventral bud, arises from the hepatic 
diverticulum, connects directly to the CBD.  
• The duct from the larger dorsal bud, arise from the duodenum.  
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The  ventral anlage duct becomes the duct of Wirsung, and  the 
dorsal anlage duct becomes the duct of Santorini. The ducts from each 
anlage  fuse together, in the pancreatic head such that, most of the 
pancreas drains through the main pancreatic duct (MPD) or the 
Wirsung. 
The  common channel length is often variable. In  one third of the  
patients, the CBD and MPD remains separate till joining the papilla; in 
another third    the two ducts may merge at the papilla, and in the 
remaining third few millimeters of  true common channels persist.  
 The duct of Santorini, persist as the lesser pancreatic duct.It 
drains  into the duodenum through the lesser papilla,lying  proximal to 
the major papilla. In approximately 30% of patients, the Santorini duct 
ends as a blind accessory duct . In 10% of patients, the ducts of Wirsung  
and Santorini , fail to fuse with each other. This ends up with the 
majority of drainage via the duct of Santorini and lesser papilla. The  
pancreatic head and uncinate  process, drains via the duct of  Wirsung 
and major papilla. This normal  variant, occuring in 10% of patients, is 
referred to as pancreas divisum. In a minority , the lesser papilla can’t 
be able to handle the flow of pancreatic juices . This relative outflow 
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obstruction  resulting in pancreatitis,is treated by sphincteroplasty of the 
minor papilla. 
 
 
 
 
 
 
The MPD is normally  2 - 3 mm in diameter. The MPD pressure  
is about twice that of  the CBD, which  prevents the  bile reflux into the 
pancreatic duct.  
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The ampullary muscle fiber forms the sphincter of Oddi, 
controling the  biliary and pancreatic secretions into the duodenum. 
Both hormonal and neural factors regulate the sphincter. When the 
accessory pancreatic duct or lesser duct opens into the duodenum, a 
lesser papilla is identified 2 cm proximal to the major papilla. 
Arterial supply 
The pancreas derives its arterial supply from  the celiac axis and 
the superior mesenteric artery7, 8. 
The coeliac axis gives the common hepatic artery, giving  rise to 
the gastroduodenal artery ,continuing  as the hepatic artery proper. The 
gastroduodenal trunk continues as  superior pancreatico-duodenal artery,  
branching into the anterior and posterior divisions. The superior 
mesenteric artery, behind the neck of pancreas,  gives off the inferior 
pancreatico-duodenal artery, branching  into the anterior and posterior 
divisions. 
12 
 
 
The superior and inferior pancreatico-duodenal arteries 
anastomose within  the  pancreatic head, along the medial aspect of the 
C-loop of duodenum, forming an arcade,giving off numerous branches 
to the duodenum and the pancreatic head. Therefore, it is impossible in 
resecting the pancreatic head, without devascularizing the duodenum.  
The  pancreatic body and tail  are supplied by splenic artery 
branches. They are the dorsal ( the transverse pancreatic artery), great, 
and caudal pancreatic arteries. These arteries form  an arcade within the  
pancreatic body and tail, which  accounts for  the organs rich blood 
supply. 
 
13 
 
Venous drainage 
 The venous drainage follows the pancreatic  arterial supply7, 8. 
The veins are usually superficial to the arteries within the parenchyma 
of the pancreas, forming  an anterior and posterior venous arcade. The 
superior veins draining   into the portal vein and the posterio inferior 
vein  draining  into inferior mesenteric vein. The antero-inferior 
pancreaticoduodenal vein, joins the right gastro-epiploic vein and the 
middle colic vein, forming a common venous trunk, draining into the 
superior mesenteric vein(SMV). Traction on the transverse colon, 
during colectomy can tear these  veins, making control tedious,as they 
retract into the parenchyma.  Numerous small venous branches, from the 
pancreatic parenchyma drain directly into the lateral and posterior 
aspect of the portal vein. The body and tail of the pancreas drains into 
the splenic vein. 
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Lymphatic drainage 
The pancreas has a rich lymphatic drainage and follows the 
venous drainage7. It is due to the diffuse lymphatic drainage,  pancreatic 
cancer  presents with positive lymph nodes and  a high  local recurrence 
. Lymph nodes are palpated, along the posterior aspect of pancreatic 
head, in the pancreaticoduodenal groove, along the inferior border of the 
pancreas, along the hepatic artery ascending into the portahepatis, and 
along the splenic artery and vein. The pancreatic lymphatics also 
communicates with lymphatics in the transverse mesocolon and the 
mesentery of the proximal jejunum. Tumors in the body and tail, often 
metastasize to these nodes.          
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Nerve supply 
The pancreas is innervated by both sympathetic via splanchnic 
nerve & parasympathetic via vagus nerve7, 8. The acinar cells ,which are 
responsible for exocrine secretion and  the islet cells,which are  
responsible for endocrine secretion are innervated by both  the systems. 
The parasympathetic system stimulates the endocrine and the exocrine 
secretion and the sympathetic system inhibits the secretion. The 
pancreas is also innervated by neurons that secrete amines and peptides, 
such as somatostatin, calcitonin gene-related peptide (CGRP), 
vasoactive intestinal peptide (VIP), and galanin.  
The pancreas also has afferent sensory fibers, which are 
responsible for the intense pain in advanced pancreatic cancer and  
pancreatitis. Interrupting   these somatic fibers travelling towards the 
celiac ganglion can stop the transmission of pain sensation in the 
pancreatic disease. 
16 
 
 
Histology 
Pancreas has both exocrine and  endocrine glandular tissues. The 
exocrine pancreas consists of acinar glands, whereas the endocrine part 
consists of islets of Langerhans10. 
The pancreas contains 85% of exocrine gland, 10%  of 
extracellular matrix, and 4% of blood vessels & the major ducts, and 
only 2% of endocrine tissue11. Thus the endocrine and exocrine pancreas 
is thought to be functioning separately, but coordinated well for 
regulating the feedback system of digestive enzyme and hormone 
secretion. 
The acinar cells, so named because they are clustered like grapes 
on the stem. The main duct ramifies into intralobular and interlobular 
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ducts, ductules and finally acini, that secretes into a centrally located 
acinar space that communicates with the main pancreatic duct. 
Histologically, acinar cells have a high content of endoplasmic 
reticulum with  apically located eosinophilic zymogen granules. The 
cells lining the main pancreatic duct are tall columnar cells, and many 
contain mucin granules. With progression from the large ducts to the 
smaller intralobular and interlobular ducts, the lining cells become 
flatter, assuming a cuboidal configuration, and mucin granules are no 
longer seen. Centroacinar cells, located at the junction between ducts 
and acini, resemble acinar cells in size and shape but lack zymogen 
granules7. 
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 The islets of Langerhans are distributed throughout the pancreas. 
Capillaries draining the islet cells drain into the portal vein forming a 
pancreatic portal system. 
Surgical physiology 
In response to a meal, the duodenal mucosa releases the hormone 
secretin ,which stimulates the pancreas to secrete an alkaline  
bicarbonate-rich enzymes with a pH of 8.4. Cholecystokinin-
pancreozymin (CCK), released from the duodenal mucosa , produces no 
increase in the volume of secretion, but is responsible for enzyme 
secretion. Vagal stimulation increases the  volume. Approximately  
6 - 20 gm of digestive enzymes enters the duodenum each day7, 8.  
Exocrine Pancreas 
The pancreas secretes about 500 to 800 mL of odourless, 
colourless, isosmotic, alkaline, pancreatic juice daily7. Pancreatic juice 
is made up secretions from ductal and acinar cells, which are 
responsible for digestion of carbohydrate, protein, and fatty foods. 
Pancreatic amylase, the only enzyme secreted in the active form. 
All other enzymes are secreted in the proenzymes form.. Trypsinogen 
has several isoforms and a missense mutation on the cationic 
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trypsinogen, results in  intrapancreatic activation of trypsinogen12 
accounting for the  hereditary pancreatitis. 
 
 
 
 
 
 
 
Endocrine Pancreas 
In adults,about 1 million pancreatic islet cells are present with 
sizes from 40 – 900 µm. Larger cells lie close to major arterioles and 
smaller cells are embedded deeply in the parenchyma.  
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Most islets contain five major types of cells:  
1. α cells - secretes glucagon(20%)  
2. β cells - secretes insulin(75%)  
3. δ cells - secretes somatostatin  
4. ε cells - secretes ghrelin and 
5. PP cells - secretes pancreatic polypeptide. 
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ACUTE PANCREATITIS 
Definition: 
Acute pancreatitis is “an inflammatory disease, associated with, 
little or no fibrosis of the pancreas”, several initiating factors including  
gallstones, alcohol, trauma, and infections, and, rarely hereditary7.  
Etiology of acute pancreatitis: 
Acute Pancreatitis is multifactorial. On the basis of  the 
worldwide data, the most common cause is gallstones,  accounting  for  
45 percent of cases. Alcoholism is the second common cause, 
accounting for 35 percent of cases. In a study done at New Delhi, India, 
gall stones and alcoholism were found to be the cause of pancreatitis in 
49% and 23.6%  of cases, respectively13. 
The disease occurs at a higher rate in young men and old women. 
Females are more prone to have gall stone pancreatitis and males are 
more prone to have alcohol induced pancreatitis14. 
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CAUSES OF ACUTE PANCREATITIS7: 
Alcohol 
Biliary tract disease 
Obstructive causes: 
• Choledocholithiasis 
• Ampullary carcinoma or pancreatic malignancy 
• Papillary obstruction by worms/foreign bodies   
• Pancreas divisum with minor duct obstruction 
• Choledochocele 
• Duodenal diverticula at periampullary region 
• Spasm of sphincter of Oddi 
Toxins or drugs:  
• Toxins:- ethanol/methanol, scorpion sting, organo phosphorous 
compounds 
• Drugs:- Definite Cause 
            5-Aminosalicylate (ASA) 
            6-Mercaptopurine (6-MP) 
           Azathioprine  
23 
 
           Cytosine arabinoside (cytarabine) 
           Didanosine 
           Diuretic agents 
           Estrogens, etc. 
 
Trauma: 
• External injury to the abdomen. 
• Iatrogenic injury- postoperative trauma, post ERCP, post 
endoscopic sphincterotomy and manometry of sphincter of 
Oddi 
Metabolic abnormalities: 
• Hypercalcemia 
• Hypertriglyceridemia 
Inherited conditions 
Infection: 
• Parasitic:- ascariasis, Clonorchis sinensis 
• Viral:- mumps,HIV,EBV,CMV rubella, hepatitis, coxsackie B, 
echo virus, adenovirus varicella. 
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• Bacterial: - Camphylobacter jejuni ,mycoplasma pneumoniae, , 
Myco. tuberculosis, legionella pnemophila, MAC, leptospiral 
infection 
Vascular causes: 
• hypo perfusion causing ischemia (e.g., after major cardio-vascular 
surgery) 
• Athero-embolism 
• Vasculitis- SLE, PAN, malignant hypertension 
Miscellaneous causes: 
• Peptic ulcer penetration 
• Cystic fibrosis 
• Crohn’s disease 
• Reye’s syndrome 
• Hypothermia 
Gall stones 
Gall stone disease, the leading cause of acute pancreatitis   
(30-60%). Women are more commonly affected , and incidence varies 
between 50 to 60 yrs of age14. 
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In 1901, Opie, Johns Hopkins Hospital , Baltimore, reported a 
case of  impaction of gallstone at  the ampulla of Vater ,following  an 
autopsy of a patient (operated on by Halsted) who  died, due to gallstone 
induced pancreatitis3.He suggested that the stone might have caused an 
outflow obstruction of the  common ‘biliopancreatic channel’, which led 
him to propose the "common-channel hypothesis3",which states that  a 
blockage below the junction of the common ducts, would cause bile to 
back flow into the pancreas to cause damage. Although this theory was 
originally favored, most observers now believe that, it is the stone-
induced pancreatic duct obstruction and ductal hypertension, rather than 
bile reflux that triggers acute pancreatitis. 
Opie’s hypothesis   dominated much of the twentieth century, but 
it is  regarded as a myth today. Lerch et al. demonstrated that pancreatic 
duct obstruction alone causes necrotizing pancreatitis. 
Another proposed mechanism is  that, passage of a gallstone 
through the sphincter of Oddi, renders it incompetent, allowing  the 
duodenal juice reflexing into the pancreatic ductal system.  
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 Microlithiasis (occult gall stones/biliary sludge)is also a   well-
known cause of acute pancreatitis. Microlithiasis is diagnosed by Biliary 
microscopy & endosonography.  
Alcohol 
Alcohol, the second most common etiological agent,accounts  for  
30% of  cases. The disease can recur with continuous abuse of alcohol. 
Various theories have been put forward7, 8: 
1. Alcohol consumption alters lipid metabolism. A transient 
hyperlipidemic state, causing hypertriglyceridemia with 
27 
 
generation of fatty acids and their metabolites, that can injure the 
pancreas. 
2. Alcohol  causes intra pancreatic generation of oxygen free 
radicals, which can injure the pancreas. 
3. It promotes secretion of pancreatic juice with high  proteolytic  
content and  low  enzyme inhibitor content. Enzyme activation 
can theoretically occur in these conditions, causing pancreatic 
injury. 
4.  "Secretion with blockage" mechanism: Ethanol produces 
sphincter of Oddi spasm , leading to ductal hypertension. Ethanol 
is a metabolic toxin to the acinar cells, interfering with enzyme 
synthesis and secretion. 
5. Secretion of enzyme-rich fluid with precipitation of protein and 
calcium within this protein matrix, causes multiple ductal 
obstructions. Continued secretion can cause pressure to buildup 
with the formation of intra-ductal plugs, which cause ductal 
obstruction and ductal hypertension. 
6. Ethanol causes focal ischemic injury to the gland,with transient 
decrease in the  pancreatic blood flow. 
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Hyperlipidemia 
It is responsible in 1.5-4 % of cases. Triglyceride level > 1000 
mg/dl increases the likelihood of developing pancreatitis. 
Hyperlipidemia type I, IV and  V can cause pancreatitis.  Lipase  
liberates large amounts of toxic fatty acids into the pancreatic 
microcirculation8 ,leading  to endothelial injury and ischemic injury. 
Hypercalcemia 
Hypercalcemia, secondary to hyperparathyroidism or any other 
cause can cause acute pancreatitis. The mechanism most likely is hyper 
secretion and  formation of calcified stones intra ductally. 
Iatrogenic Pancreatitis 
Acute pancreatitis is associated with a number of surgical 
procedures and postoperatively with Billroth II gastrectomy and 
jejunostomy, where  increased intraduodenal pressure, can cause 
backflow of the enzymes into the pancreas.It also occurs in association 
with surgery with low systemic perfusion. Atheromatous emboli or 
ischemia can cause pancreatic injury. Most commonly, endoscopic 
retrograde cholangio pancreatography (ERCP) results in pancreatitis in 
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2 to 10% of patients, due to direct injury and/or intraductal 
hypertension. 
Tumours 
About 1 to 2% of cases of  acute pancreatitis, may harbour  
pancreatic malignancy. Periampullary tumor may present as pancreatitis 
,which would be the first clinical sign. 
Drugs 
For practical reasons, it is often  difficult to implicate a drug as 
the cause of pancreatitis. A drug is considered to be a cause, if the 
pancreatitis-like illness resolves with its discontinuation. 
Infections 
Though mumps, coxsackie virus, and Mycoplasma pneumoniae 
are believed to be capable of inducing acute pancreatitis, none of these 
have been isolated, from a diseased pancreas. The antibody titres to 
mumps and coxsackie virus are elevated in about 30% of cases with 
acute pancreatitis . However, this elevation may be an anamnestic or 
nonspecific response to pancreatitis. 
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Miscellaneous Causes 
 Infestations by Ascaris lumbricoides and  Clonorchis sinensis,  
cause Oriental cholangitis, associated with cholangiocarcinoma and 
obstructing the pancreatic duct.  
A dominant gene mutation with Mendelian inheritance, is seen in 
hereditary pancreatitis. Whitcomb and associates, described  mutations 
in the cationic trypsinogen gene PRSS1, which results in acute 
pancreatitis.  
20 to 45% of patients with pancreas divisum (unfused ducts of 
Wirsung and Santorini) develop pancreatitis. The failure of procedures 
in  improving the pancreatic drainage , and reducing attacks of 
pancreatitis, contradicts pancreas divisum as an etiologic factor12.  
Finally, no cause could  be attributed  to some episodes of  
pancreatitis, and these  groups are referred to as idiopathic pancreatits15. 
Pathophysiology 
   Acute pancreatitis is triggered by digestive enzymes, which got 
activated inside acinar cells. The ultimate severity depends upon the 
event, that subsequently occurs following the acinar cell injury. The 
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events are activation and recruitment of inflammatory cell, synthesis and 
release of cytokines and other inflammatory mediators. Large amounts 
of liberated digestive enzymes however overwhelm the system as a 
whole. 
There are three reasons for this theory7, 15:  
(a)    Activated enzymes of the duodenum digest the pancreatic tissue. 
(b)  Activated  enzymes are found within the pancreas, during acute 
pancreatitis. 
(c)   The histology of pancreatitis is suggestive of a coagulative 
necrosis.  
According to “colocalization hypothesis” ,digestive enzymes are 
localized in the cytoplasmic  vacuoles. These vacuoles also contain the 
lysosomal hydrolase Cathepsin B, known to activate trypsinogen7. 
Recent studies suggest that, cathepsin B  inhibition by  specific 
inhibitor, CA-074me, protects against the intra-acinar cell  trypsinogen 
activation, and hence pancreatitis. These findings suggest that, the 
trypsinogen is activated because it erroneously colocalises in 
cytoplasmic vacuoles with cathepsin B. 
32 
 
Recent studies suggest that, activated trypsin  (appears   similar   to   
autophagic   vacuoles), mediates  the permeability of these organelles 
and release  their contents into the cytosol.  
 
 
 
 
 
  Inside the cytosol, Cathepsin B initiates apoptotic cell death by 
permeabilizing mitochondrial membranes. 
FACTORS INFLUENCING THE  PANCREATIC SEVERITY: 
The severity of acute pancreatitis varies significantly. Some  have 
a mild  form of  disease, that is self-limiting, while others suffer a  
severe form and sometimes lethal attack. Factors determining the 
severity of pancreatitis are multifactorial. Their identification is of 
considerable therapeutic significance, because their manipulation may 
decrease the morbidity and mortality associated with the disease.  
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In addition to the  neutrophils, the pancreatic acinar cells produce  
inflammatory mediators . The factors compounding  with pancreatitis 
and  lung injury include: tumor necrosis factor alpha, monocyte 
chemotactic protein-1, Mob1, interleukin-1β (IL-1β), platelet activating 
factor, substance P, adhesion molecules [intercellular adhesion 
molecule-1 (ICAM-1) and selectins], IL-6, 8, 10, C5a, the CCR1 
receptor, granulocyte-macrophage colony-stimulating factor, 
macrophage migration inhibitory factor, COX-2, prostaglandin E1, 
nitric oxide (NO) and reactive oxygen species.  Heat shock proteins are  
protective in pancreatitis The balance between the pro-inflammatory and 
anti-inflammatory factors,decide the severity of pancreatitis and lung 
injury7.  
Several therapeutic regimens aimed at reducing the inflammatory 
response. They  include  anti–tumor necrosis factor alpha antibody, IL-1 
receptor antagonist, IL-10, anti-ICAM-1 and anti-CD3 Ab, rPAF acetyl 
hydrolase, and the calcineurin antagonist FK5068.  
Recent studies also indicate that , Toll-like receptor 4 (TLR4) is 
significant in determining the severity of acute pancreatitis. The 
TLR4,by initiating a complex signaling pathway, interacts with 
lipopolysaccharides, resulting  in a proinflammatory response.  
However, this effect appears independently of lipopolysaccharides.  
TLR4 antagonists would be a good therapy, against pancreatitis15. 
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An alternate approach to prevent or reduce the severity of 
pancreatitis is, to inhibit intrapancreatic trypsinogen and NF-κB 
activation, the two events which occurs early in pancreatitis. Prior 
thermal (and arsenite) & water immersion stress, up regulates hsp 70 
and 60, respectivel. Thus preventing  cerulein-induced trypsinogen 
activation,and hence  inhibiting cerulein-induced NF-κB activation , 
hence protective in pancreatitis7, 8. 
Initiation of injury 
Block in pancreatic enzyme secretion 
Co-localization of zymogen granules and lysosomal enzymes 
Activation of trypsinogen & release of trypsin 
Activation of other zymogens 
Reactive oxygen Species               Cytokines, adhesion molecules 
Leucocyte infiltration 
Release of further cytokines (TNF, IL-6, IL-8, PAF) 
Inflammation              SIRS 
Ischemia            Multi organ failure 
Necrosis & Apoptosis 
Schematic representation of the mechanisms of pathogenesis of  
acute pancreatitis16 
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Clinical presentation: 
The clinical presentation, diagnosis, and management of an acute 
attack of pancreatitis looks similar in both acute or chronic pancreatitis. 
Acute pancreatitis can mimic like acute abdomen, and should never be 
excluded in differential diagnosis8. 
Abdominal pain, nausea, and vomiting  present as the  
predominant symptoms. Each episode begins with severe pain. The 
cardinal symptom is usually epigastric pain. The pain was described as 
"knifing" or "boring through" to the back, relieved by leaning 
forward(Mohmadian prayer position). Pain starts 12-48 hours after a 
bout of alcohol, or after a large meal in case of gall stone pancreatitis. 
Pain became generalized once peritonitis has been sets in8, 15. 
Painless pancreatitis is seen in Peritoneal dialysis, post-operative 
situations, legionnaire’s disease. 
If patient develops generalized paralytic ileus, abdominal 
distension and vomiting can occur. The vomiting may lead to gastro 
esophageal tears (i.e., Mallory-Weiss syndrome) and upper 
gastrointestinal bleeding. Vomiting is more intense in necrotizing 
pancreatitis than in edematous pancreatitis. Although vomiting and 
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retching may be relieved by passage of a nasogastric tube, the pain 
usually persists even after gastric decompression. 
Fever is an important sign. Fever presenting during  first week ,is 
due to acute inflammation, mediated by cytokines. Fever during the 
second or third week, is due to infected pancreatic necrosis. 
Physical Findings: 
            The patient may have tachycardia , tachypnoea , hypotension, 
and hyper thermia7, 8.Abdomen findings include  Voluntary and 
involuntary guarding,with decreased or absent bowel sounds . Unless 
pseudocyst develops ,pancreatitis does not present with mass. Abdomen 
may be distended due to pancreatic acites. Acute pancreatitis  may be  
associated with left sided pleural effusion. 
With increasing severity, there is  sequestrations of fluid in the 
retro peritoneum leading  to life threatening intravascular fluid 
loss,which  leads to hemoconcentration. There might be bleeding into 
the retro peritoneum or peritoneal cavity, which may dissect via the soft 
tissues, appearing  as a bluish discoloration around the umbilicus 
(Cullen's sign) or in the flanks (Grey Turner's sign) and the inguinal 
region (Fox's sign) 17. Neither sign is pathognomonic of AP. 
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 The severe intravascular fluid loss may lead to acute renal 
shutdown with elevated BUN and creatinine levels. And also there may 
be hyperglycemia, hypoalbuminemia, and hypocalcemia that are 
sufficient enough to produce tetany in few cases. 
Diagnosis: 
The clinical diagnosis is one of exclusion and diagnosis may be 
difficult ,despite the multiple serological and radiological investigations 
are available. 
Serum pancreatic enzymes: 
Serum pancreatic enzyme estimation,the gold standard for 
diagnosis18. The reason is pancreatic acinar cells synthesize, store, and 
secrete a large amount of digestive enzymes (e.g., amylase, lipase, 
trypsinogen, and elastase), which gets elevated in acute pancreatitis. 
Amylase, lipase, elastase and trypsin were secreted in the blood at 
the same time, but their clearance differs due to the  different 
sensitivities. 
 Serum amylase concentration will increase immediately, reaches 
the peak , within several hours after the onset of disease ,remains raised  
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for 3 to 5 days and then  returns back to normal. No significant 
correlation has been found, between the level  of serum amylase  and 
severity of pancreatitis. Hyperamylasemia is also seen in biliary tract 
disease, intestinal obstruction, mesenteric ischaemia,  acute appendicitis, 
mumps, parotitis, impaired amylase excretion etc…18. In contrast, a 
patient with acute pancreatitis may even have a normal serum amylase 
level, because of the interference by lipids, with chemical determination 
of serum amylase.  Urinary amylase clearance  increases during 
pancreatitis; predicting better results than serum amylase. For these 
reasons, it is recommended to measure the urinary amylase , which 
usually remain elevated for several days after serum amylase levels have 
returned back to normal. In patients with severe necrotic pancreatitis , 
the pancreas may not release large amounts of enzymes . 
The serum lipase  has been found to be  highly  sensitive and 
specific, in diagnosing acute pancreatitis, as there are no other sources 
of lipase15, 17. Total amylase is having a sensitivity of 84%, the serum  
P- amylase has 95% and lipase has 93%. Specificities for amylase,  
P-amylase and lipase respectively are- 88%, 93% and 96%, respectively. 
Thus P-amylase is the enzyme with the higher diagnostic value. 
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The rise of lipase: amylase has been found to differentiate 
alcoholic from nonalcoholic pancreatitis. The serum (SGPT) alanine 
aminotransferase level rise of three or more times above the base-line 
value has great specificity in diagnosing gallstone pancreatitis. 
Immunologic assay like serum trypsinogen or immune lipase are 
generally less specific than the lipase assay. The increased urinary level 
of activated peptides, released by trypsinogen, procarboxypeptidase, or 
prophospholipase activation, may aid in predicting the severity of an 
attack.  
Leucocyte migration and its activation, is considered as a major 
determining factor of local & systemic complications8, 15.  
Although methemalbumin rise  indicates severe pancreatits and  a 
poor prognosis, methemalbumin levels are usually not measured. 
Circulating levels of several inflammatory mediators and acute phase 
reactants  
(e.g., IL-1, 6, TNF-alpha, and CRP) also increase during pancreatitis, 
and the magnitude of those increases can be used to predict the severity 
of an attack. C reactive protein is readily available in all centers and 
vales > 120mg/L, after 72 hours are closely related to necrotising 
pancreatitis. 
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Imaging: 
In general, the plain chest and abdominal radiographs can be 
useful in the management, by identifying other causes for the patient's 
symptoms (e.g., pneumonia, perforated hollow viscous, mechanical 
bowel obstruction). Plain abdominal X-ray findings are either 
generalized or localised ileus ( sentinel loop), colon “cut-off” sign or 
“renal halo” sign. A chest radiograph may show left pleural effusion, 
elevated left hemi diaphragm or basal atelectasis17. 
Ultrasonography: 
Abdominal ultrasound (US) examination is the gold standard for 
confirmation of gallstones pancreatitis. It is also helpful to detect extra 
pancreatic ductal dilations & pancreatic edema, swelling, free peritoneal 
fluid and peripancreatic acute fluid collections (PFCs).It may not be 
sensitive in about 20% of cases, due to bowel gas interference with the 
imaging. 
CT scan: 
The contrast-enhanced computed tomography (CECT), has 
become gold standard for17 
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• Diagnosis 
• Assessing the severity 
• Identify the complications associated with acute pancreatitis. 
The Balthazar scoring system and other similar grading systems 
have incorporated various CT findings such as inflammation and fluid 
collections in & around the pancreas to correlate radiographic 
appearance with morbidity and mortality19.  
Early CT scans often fail to detect evolving necrosis, which 
would become well demarcated by 2 to 3 days after the onset of 
symptoms. The CT scans are not useful in diagnosing necrosis or 
predicting the severity in the first 24 hours of illness. The sensitivity for 
identifying pancreatic necrosis using contrast-enhanced CT scan 
approaches 100%, 4 days from diagnosis. CT scans is useful in the early 
diagnosis of infected pancreatic necrosis and image guided aspiration of 
necrosis, when patient not improving clinically or who experience 
clinical decline. In the patient with moderate renal impairment or allergy 
to intravenous contrast material, magnetic resonance imagining (MRI) 
may be useful. MRI has been found to have sensitivity and specificity 
similar to contrast-enhanced CT, for detecting severe acute pancreatitis. 
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ERCP should be done in patients with acute pancreatitis , whose 
clinical course fails to improve despite full intensive care support, and in 
whom ampullary or common bile duct stone impaction is suspected, 
based on ultrasonography, or clinical/biochemical signs of cholangitis. It 
may also be helpful in patients ,with recurrent attacks of acute 
pancreatitis, without any obvious cause. It is useful in correcting 
potentially correctable lesions such as CBD stones with impaction, 
pancreas divisum, ampullary stenosis, pancreatic duct stenosis etc. 
Assessment of Severity: 
Assessment of  mild and severe necrotizing pancreatitis, is the 
most important thing for providing optimal care to the patient7. There 
are so many predictors available for assessing the severity, which 
includes early prognostication signs, serum markers, and CT scan15. 
Scoring systems in acute pancreatitis:  
The various prognostic scoring systems for assessing the severity 
will be discussed in detail later. 
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UK guidelines for the management of AP20: 
• Diagnosis should  be made within 48 hrs. of admission. 
• The etiology has to be determined in 80% of cases at least and 
idiopathic cause should not exceed 20%. 
• The serum lipase assay has been preferred over serum amylase 
assay for diagnosis the acute pancreatitis. 
• The contrast enhanced computed tomography has to be preferred 
over USG for detection of the presence/absence of pancreatitis. 
Treatment:  
Evolution of an acute attack of pancreatitis occur in two phases, 
overlapping on each other15, 17.  
The initial phase, lasting for 1 to 2 weeks, involves an acute 
inflammatory and autodigestive process. It may have systemic effects as 
well.  
The second phase, that may last for weeks or months, is primarily 
characterized by the development of local complications that are, 
themselves, the results of necrosis, infection and pancreatic duct rupture. 
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The initial management of patients with pancreatitis focuses on 
early establishment the diagnosis, assessing the severity, treating the 
major symptoms, and haltering the disease progression. The treatment 
for acute pancreatitis is largely supportive. Since 15-30 % patients 
develop severe pancreatitis, so each and every patient should be treated 
aggressively. The main aim of the treatment is ‘allowing rest to the 
gland’ by oral feed and fluids restriction21. The goal of initial 
management consists of adequate fluid replacement,nutritional support, 
correction of electrolyte imbalance, and prevention of local & systemic 
complications. 
Management of Pain 
Good analgesics should be given to these patients as the pain can 
be very severe in intensity. Most patients require narcotic analgesics. 
Meperidine is preferred as morphine induces spasm of the sphincter of 
Oddi, which can, at least theoretically, worsen biliary pancreatitis. 
Fluid and Electrolyte Management 
Aggressive fluid resuscitation is important to replenish 
extravascular, or "third space," fluid loss, which may be considerable. 
The fluid resuscitation is of utmost importance to prevent systemic 
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complications, mainly acute renal insufficiency, that may occur with 
hypovolemia. Transudation of the fluid from intravascular space into the 
areas of inflammation (i.e., peripancreatic, retroperitoneum and into the 
pulmonary parenchyma and soft tissues elsewhere in the body) is the 
principle cause of hypovolemia. Furthermore, studies have shown that 
inadequate resuscitation may add upon as a significant risk that leads to 
further pancreatic injury.  
Banks and colleagues have showed that, aggressive fluid 
resuscitation would  not prevent the progression of  developing  
pancreatic necrosis. The degree and intensity of monitoring depends 
upon the disease severity22.  
During the first several days of a severe attack, circulating levels 
of many proinflammatory factors, including cytokines and chemokines, 
are elevated. This so-called “cytokine storm”, in many cases, triggers 
the systemic immune response syndrome, and as a result, the 
hemodynamic parameters of these patients may resemble those of sepsis 
associated with other disease states23. Heart rate, cardiac output, and 
cardiac index usually rise, and total peripheral resistance falls. 
Hypoxemia can also occur as a result of the combined effects of 
increased intrapulmonary shunting and a pancreatitis-associated lung 
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injury that closely resembles that seen in other forms of ARDS. Fluid 
management, though critical, may be difficult when hypovolemia is 
combined with respiratory failure of ARDS.  
Measurement of central filling pressures, using a Swan-Ganz or 
central venous pressure catheter, can be helpful in guiding fluid 
management, particularly when hypovolemia is combined with lung 
injury. 
Nasogastric Decompression 
The nausea and vomiting of pancreatitis can result in significant 
fluid as well as electrolyte losses and retching can lead to gastro-
esophageal mucosal tears and result in upper gastrointestinal bleeding 
(i.e., the Mallory-Weiss syndrome). For symptomatic relief and to 
increase patient comfort, nasogastric decompression may be needed, 
although the institution of nasogastric drainage does not shown to alter 
the eventual outcome of an attack7, 8. 
Prophylactic Antibiotics 
Infection is a serious complication of acute pancreatitis and is the 
most common cause of death17. It is mostly caused by the enteric 
bacteria and was seen commonly in necrotizing pancreatitis. Local 
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infection occurs with pancreatic necrosis, and  as time progresses for at 
least the first 3 weeks,the disease progresses. Aerobic and anaerobic 
gastrointestinal floras are the primary organisms involved, and 
infections may be either mono or polymicrobial in nature. The 
predominant microbes seen were E. coli (35%), Kleb. pneumoniae 
(25%), Streptococcus (25%), Staphylococcus (15%), and Pseudomonas 
(10%).The association of high mortality with pancreatic infection has 
been the rationale behind the use of prophylactic antibiotics widely in 
patients with pancreatic necrosis. In severe pancreatitis, beneficial 
effects have been observed with regimens that included imipenem alone, 
imipenem with cilastatin, metronidazole and third-generation 
cephalosporin (cefuroxime). Because Candida species are common 
inhabitants of the upper GI tract, Candida sepsis and secondary fungal 
infection of pancreatic necrosis is a risk in severe disease, and many 
surgeons advocate empirical therapy with fluconazole in severe acute 
pancreatitis. 
The duration of treatment has not defined clearly. A treatment 
course of 1week to 4 weeks has been recommended commonly, but 
many of them limit the treatment to 2 weeks17. 
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According to the current UK guidelines (Johnson 2005), the 
duration of antibiotic prophylaxis is 1 to 2 weeks20. 
Nutritional Support 
Classically speaking, the enteral feeding should be limited, 
thereby pancreatic stimulation and further pancreatic injury by the 
release of proteolytic enzymes can be avoided. Recent data, suggests 
that such strict limitations of enteral nutrition may have been 
unnecessary. Most of the severe acute pancreatitis patients found to 
have prolonged course of illness with hyper catabolic state and ileus that 
have led to a generous use of parenteral nutrition in them. 
The points favoring enteral nutrition are7, 15:  
 It might feasible, safe, and desirable in severe pancreatitis.  
 It has the advantage of avoiding the high cost of total parenteral 
nutrition (TPN) as well as its associated catheter-related 
complications. 
 The use of enteral nutrition may support intestinal mucosal 
integrity by avoiding the alteration in intestinal permeability & 
barrier function as seen with use of TPN.  
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Treatments of Limited or Unproven Value 
In patients who develop severe disease, other treatment modalities 
may be tried.  The antiproteases like gabexate/aprotinin, antisecretory 
agents like octreotide and anti-inflammatory drugs or PAF antagonists 
like lexipafant were found to be less useful15, 17.  
Treatment of Early Systemic Complications of Pancreatitis 
The pathogenesis and management of the cardiovascular collapse, 
respiratory failure, renal failure, metabolic encephalopathy, 
gastrointestinal bleeding, and disseminated intravascular coagulation 
that complicate severe pancreatitis appear to be identical to those 
involved when these processes are superimposed on other disease states 
that are characterized by peritonitis and hypovolemia8.  
Cardiovascular collapse is largely caused by hypovolemia, and its 
management requires aggressive fluid and electrolyte repletion.  
The pulmonary manifestations of pancreatitis include atelectasis 
and acute lung injury. The latter appears to be similar to the acute lung 
injury caused by other systemic processes, including septic shock, 
ischemia and reperfusion, and massive blood transfusion. Management 
includes good pulmonary toilet combined with close monitoring of 
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pulmonary function. For many patients, intubation and respiratory 
support may be required.  
Renal failure in pancreatitis is usually prerenal and is associated 
with a poor prognosis,sometimes requiring hemodialysis. 
Stress-induced gastro duodenal erosions account for most of the 
gastrointestinal bleeding, prophylaxis with antacids, H2-receptor 
antagonists, or proton pump inhibitors may be appropriate.  
Rarely, massive bleeding can result from injury to peripancreatic 
vascular structures, leading to hemorrhage into the retroperitoneum. The 
peripancreatic inflammatory process can also cause thrombosis of major 
gastrointestinal vessels and result in ischemic lesions involving the 
stomach, small intestine, or colon that can cause bleeding. Management 
of these complications of pancreatitis is similar to that involved when 
they occur in the absence of pancreatitis.  
Some patients with severe pancreatitism, develop DIC, but it 
rarely causes bleeding, and rarely needsprophylactic heparin. 
Removal of precipitating factors, such as drugs or alcohol, is 
appropriate. Once the acute phase has been survived, by the end of the 
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first week, then local complications become pre-eminent in the 
management of these patients. 
An indication for operative intervention in acute pancreatitis is 
the drainage of an infected pancreatic necrosis. These patients require 
removal of as much as possible of the infected necrosis and drainage for 
the remaining viable exocrine tissue. Current opinion is against 
debridement in sterile necrosis unless it is accompanied by life 
threatening systemic complications17. 
A pancreatic abscess usually occurs 2 to 6 weeks ,after an initial 
attack of acute pancreatitis, in contrast to infected necrosis ,which 
occurs in the first few hours or days. Treatment consists of external 
drainage, either by surgical or percutaneous catheter based measures17. 
Treatment of Biliary Pancreatitis 
The presence of gallstones leading to choledocholithiasis is 
recognized as a major etiological factor worldwide. Endoscopic 
retrograde cholangio pancreatography (ERCP) has both diagnostic and 
most therapeutic utility in patients with biliary obstruction or 
cholangitis. By randomizing patients with AP to early ERCP versus no 
ERCP, both Neoptolemos and colleagues, and Fan and colleagues have 
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showed a significant decrease in morbidity but there was no significant 
improvement in mortality with routine use of ERCP. A metacentric 
randomized control study in the ERCP group by Folsch and colleagues 
recently, have demonstrated increased complication rate and mortality 
rate, after excluding the patients with biliary sepsis or obstruction. It 
therefore, found that early ERCP may be harmful even in the absence of 
ongoing biliary obstruction. Magnetic resonance cholangio 
pancreatography (MRCP) is an additional alternative to ERCP as a 
diagnostic tool that avoids the risk of post procedure pancreatitis. 
In general, cholecystectomy as an early intervention, within the 
first 48 to 72 hours of admission, or delayed intervention (after 72 
hours, but during the initial period of hospitalization) may be favored8, 
15. Cholecystectomy with intra-operative CBD exploration is probably 
the best option for  obstructive pancreatitis. However, high risk patients 
are best treated by endoscopic sphincterotomy, with clearance of stones 
by ERCP. 
Surgical Management: Indications and Timing 
Limited indications prevail for surgical intervention.Intervention 
is needed to address the etiology of pancreatitis or its complications. 
Suspected choledocholithiasis needs open or laparoscopic intervension. 
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Delayed surgery is also, rarely needed for the treatment of local 
complications like pseudocysts17.  
 
Early surgical intervention leads  to  hemorrhage from the 
pancreatic bed, which may be  difficult to control because the  
endarteritis obliterans was incomplete. Moreover the delineation 
between viable & non-viable tissue might not be clearly made out. 
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Complications17: 
 
Complications may be classified as15, 17: 
I.  LOCAL: 
Fluid collections 
Pancreatic ascites/pleural effusion 
Pancreatic pseudocyst 
 Pancreatic necrosis 
 Infected pancreatic abscess 
 Hemorrhage/pseudo aneurysm 
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II. REGIONAL: 
Venous thrombosis 
Paralytic ileus 
Intestinal obstruction 
Intestinal ischemia/necrosis 
Cholestasis 
III. SYSTEMIC: 
A. Pulmonary 
1. Pneumonitis, basal atelectasis 
2. ARDS 
3. Pleural effusion (L) 
B. Cardiovascular 
1. Hypotension 
2. Hypovolemia 
3. Sudden arrest &death 
4. Nonspecific ECG(ST-T wave) changes 
5. Pericardial effusion 
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C. Hematologic 
1. Hemoconcentration 
2. Disseminated intravascular coagulopathy  
D. GI hemorrhage 
1. Acid peptic disease 
2. Gastric erosion 
3. Portal/splenic vein thrombosis with variceal bleed  
E. Renal 
1. Oliguria 
2. Azotemia 
3. Renal vessel thrombosis 
F. Metabolic 
1. Hyperglycemic state 
2. Hypocalcemic state 
3. Hyperlipidemia (triglyceridemia) 
4. Metabolic encephalopathy 
5. Sudden loss of vision (Purtscher's retinopathy) 
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G. Central nervous system 
1. Acute psychosis 
2. Fat embolism occlusion 
3. Alcohol withdrawal syndrome (AWS) 
H. Fat necrosis 
1. Intra-abdominal saponification 
2. Subcutaneous tissue necrosis 
SCORING SYSTEMS IN ACUTE PANCREATITIS 
Pancreatitis is a serious disease with high morbidity and mortality 
rates. Some 80% were mild attack which recovers rapidly with 
conservative management. The rest of 20% were severe, with protracted 
course that needs intensive care and specialized management. Several 
predictors of severity are commonly used for this purpose24. 
Scoring systems can be used in predicting mortality, severity of 
disease and intensity of its complications. Prognostic factor analysis 
found to help in comparing the results, in-between the series of patients 
under study. 
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These systems include25: 
• Ranson’s criteria  
• Balthazar computed tomography (CT) grading 
• Imrie Glasgow coma score (GCS) 
• Bank’s clinical Criteria 
• Simplified Acute Physiology Score(SAPS) 
• Marshall Multiple organ failure (MOF) score and 
• Acute physiology and chronic health evaluation (APACHE) I, II, 
III & O.  
The GCS and Ranson’s multiple scoring systems, require 48 
hours of data collection; however, APACHE can be calculated at any 
time and shows prognostic correlation with acute pancreatitis, as 
increasing scores are associated with poor prognosis. 
Once the acute pancreatitis has been diagnosed, assessment of 
severity is extremely important for execution of appropriate measures, 
preferably in an ICU setup with close monitoring. 
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AIMS AND OBJECTIVES OF THE STUDY 
1. To know the usefulness of urine trypsinogen-2 in accurately 
diagnosing acute pancreatitis 
2. To compare the diagnostic role of urine trypsinogen-2 with that of 
serum amylase, serum lipase and imaging studies in acute 
pancreatitis. 
MATERIALS AND METHODS 
Study design: Comparative Analytical study. 
Setting: Department of General Surgery, Govt. Stanley Medical College 
and Hospital, Chennai. The study was conducted after obtaining the 
Institutional Ethical Committee approval (annexure 2). 
Inclusion criteria:  
1. Patients presenting with features suggestive of acute pancreatitis 
2. Male and female subjects of age between 20 - 60 years shall be 
selected. 
3. Adult subjects willing to give informed consent. 
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• Exclusion criteria: 
1. Subjects below the age of 20 years and above the age of 60 years  
2. Subject who are not willing to participate in the study 
•  
3. Individuals who are cognitively impaired and/or who are unable 
to give informed consent. 
4. Proven cases of chronic pancreatitis and  pancreatic cancer 
5. Hereditary pancreatitis, cystic fibrosis 
METHODOLOGY 
• Patients presenting with  acute upper abdominal symptoms like 
pain, vomiting, abdominal distention, admitted in the emergency 
department of our hospital from January 2013 to November 2013 
are enrolled in the study.  
• Urine sample were obtained from all the patients and tested with  
Spot Urine trypsinogen-2 dipstick. 
• Serum amylase and serum lipase  tests were also simultaneously 
done in these patients.  
62 
 
• Patients are also evaluated with  (USG) abdomen and (CECT) 
abdomen,if required.  
• Final diagnosis of acute pancreatitis is made on the basis of 
clinical picture, serum amylase more than threefold rise and 
radiological findings. 
•  Urine trypsinogen-2 dipstick test  were compared with serum 
amylase, serum lipase and imaging studies in patients with final 
diagnosis of acute pancreatitis   
• Observations are tabulated according to the pre-designed 
proforma.   
• The results are analyzed using Microsoft Excel for tabular 
transformation and graphical representation. For comparing the 
parameters, Chi Square test or Fischer’s exact test are used. SPSS  
software will be used for statistical analysis. 
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OBSERVATION &RESULTS 
This study was conducted in the Department of General Surgery, 
Govt. Stanley Medical College & Hospital, Chennai for a period of one 
year. The 100 persons ,who fulfilled the inclusion criteria ,were enrolled 
in this study, after obtaining an informed consent. 
Table: 1 AGE DISTRIBUTION 
 
 The age group of patients enrolled in this study ranges from 20 to 
80 yrs. The peak incidence was noted in the 4th decade of life. 
 
 
Age Range (years) No. of patients Percentage (%) 
21yrs - 30yrs 24 24 
31yrs - 40yrs 25 25 
41yrs - 50yrs 36 36 
51yrs - 60yrs 13 13 
>60yrs 2 2 
Total 100 100 % 
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Figure : 1 AGE  DISTRIBUTION 
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Table: 2 GENDER DISTRIBUTIONS 
Sex No. of patients Percentage (%) 
Male 84 84 
Female 16 16 
Total 100 100 
 
Out of 100 patients enrolled in this study, there were 84 male and 
16 female patients.  
Male: Female ratio-5.25:1 
Figure:2 GENDER DISTRIBUTION 
 
 
66 
 
Table:3  GENDER DISTRIBUTION IN ACUTE PANCREATITIS 
Gender Acute pancreatitis(61) Percentage(%) 
MALE 57 93.44 
FEMALE 4 6.55 
 
Of the total cases of Acute Pancreatitis,93% of patients were male 
and the rest were female. 
Figure:3 GENDER DISTRIBUTION IN ACUTE 
PANCREATITIS(n=61) 
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Table: 4 CLINICAL FEATURES: 
Symptoms No. of patients Percentage (%) 
Pain abdomen 61 61 
Fever 25 25 
Vomiting 54 54 
Jaundice 12 12 
Abdominal distension 32 32 
 
On clinical presentation,61% of patients  presented with 
abdominal pain as chief complain. Rest of the patients had vomiting, 
abdomen distension and fever along with the  presenting symptoms.  
Figure:4 CLINICAL FEATURES 
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Table: 5 ETIOLOGY 
Etiology No. of patients Percentage (%) 
Alcohol 53 86.89 
Gall stone disease 5 8.19 
Post ERCP 1 1.64 
Hypertriglyceridemia 2 3.28 
Total  61 100 
 
History of consumption of alcohol and the possibility of it being 
the etiological factor were found in 53 patients. Gall stone disease was 
attributed in 5 patients. Hyperlipidemia and Post ERCP, as a causative 
factor  in 2 & 1 patients, respectively. 
Figure: 5 ETIOLOGY 
 
69 
 
Table:6  COMPARISON OF  DIFFERENT PARAMETERS   
USED IN  THE DIAGNOSIS OF ACUTE PANCREATITIS 
Parameters Acute 
Pancreatitis(61) 
Others(39) Total(100) 
AMYLASE 45 4 49 
LIPASE 36 4 40 
USG 53 - 53 
CECT 14 - 14 
TRYPSINOGEN 48 3 51 
 
Table:7  COMPARISON OF SENSITIVITY AND 
SPECIFICITY OF DIFFERENT PARAMETERS 
Parameters Sensitivity Specificity 
AMYLASE 73.77 89.74 
LIPASE 59.02 89.74 
TRYPSINOGEN 78.69 92.31 
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Table 8:  ESTIMATION OF SIGNIFICANCE OF THE TEST 
Urine  
trypsinogen 
Acute 
Pancreatitis 
Non pancreatic 
causes 
Total 
Positive 48 3 51 
Negative 13 36 49 
TOTAL 61 39 100 
 
Sensitivity= a/(a+c) ;48/61=78.6% 
Specificity=d/(b+d);36/39=92.3% 
Using Kappa statistics the value was found to be 0.67 
(Based on criteria originally proposed by Landis and Koch: kappa 
values greater than about 0.75 are often taken as representing excellent 
agreement; those between 0.4 and 0.75 as fair to good agreement; and 
those less than 0.4 as moderate or poor agreement.) 
FIGURE 6: ANALYSIS OF TRYPSINOGEN TEST  
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DISCUSSION 
Trypsinogen, a precursor of trypsin is  required for protein 
digestion. Premature trypsin activation  leads to pancreatic self-
digestion. Trypsinogen is a 25-kd pancreatic proteinase. In human 
pancreatic juice, there are three trypsinogen (TPS) isoenzymes, namely, 
cationic (TPS-1) and anionic TPS (TPS-2), and a minor isoenzyme 
(TPS-3).  
The inactive form of trypsinogen,stored  in the cytoplasmic 
zymogen granules of pancreatic acinar cells, are secreted into the 
adjacent duct lumen and are subsequently delivered to the small 
intestine.Within the intestine, they  are  activated by enterokinase.  
Premature  activation of trypsinogen to trypsin within the pancreas,is the 
prime pathophysiologic event, in the development of acute pancreatitis. 
Under normal conditions, trypsinogen are secreted into pancreatic fluid, 
and only a small amount enters  the circulation. For unknown reason, 
the tubular reabsorption  of trypsinogen-2 is lower than trypsinogen-1. 
The urinary trypsinogen-2 dipstick test is proposed to be, a rapid 
and simple method for the early diagnosis of acute pancreatitis.  Urine 
trypsinogen-2 concentrations were measured using a dipstick test 
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(Actim Pancreatitis, Medix Biochemica Oy AB,Kauniainen,  Finland) 
based on an immunochromatography assay. The detection limit of the 
test is approximately 50 ng/mL. The test strip has a control line and  two 
lines indicate a positive result. The test results can be read after  
5 minutes. 
   The test strip, dipped into the urine sample, contains   
trypsinogen-2 bound to monoclonal antibody labelled blue latex 
particles, which migrate across a nitrocellulose membrane with a zone 
containing another antibody specific for epitope on trypsinogen-2. 
 Two retrospective studies[10, 27] carried out by a Finnish group 
showed that Urine Trypsinogen-2 had better sensitivity and specificity 
in predicting Acute Pancreatitis than amylase and lipase. A later larger 
prospective cohort study[28] by the same group enrolling 53 patients 
with AP and 447 patients with AAD (non-pancreatic) showed that Urine 
Trypsinogen-2 has a sensitivity of 94% and a specificity of 95%, better 
than serum amylase (85% and 91%) and urinary amylase (83% and 
88%) in predicting Acute Pancreatitis. 
Sensitivity of amylase and lipase was found to be 73.77% and  
59.02% respectively, whereas as sensitivity of trypsinogen was found to 
be 78.69%. Specificity of amylase and lipase was found to be 89.74% 
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and 89.74% respectively, whereas as specificity of trypsinogen was 
found to be 92.1%.Analysing the data,it is found that sensitivity and 
specificity of trypsinogen is higher than the routine investigations. 
Eventhough it has a low range of sensitivity, its high specificity ensures 
that the test can be used as a screening test to check the true negative 
cases. 
False positive results is seen in 3 of the 39 non-pancreatitis cases, 
namely two cases of Gallstones and one case of renal failure. In case of 
renal failure, defect in the excretion  of  trypsinogen makes the result 
positive. In case of gallestone, studies with more sample size has to be 
conducted to analyse the etiology of the positivity of  the test.  
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CONCLUSION AND SUMMARY 
 
1. Urine Trypsinogen-2  dip stick test is a simple, rapid, easy, and 
noninvasive  test which can diagnose or rule out, most of the 
cases of acute pancreatitis. 
 
2. Urine Trypsinogen-2 estimation doesn't require laboratory 
facilities. It is undertaken almost instantaneously (within 5 
minutes) as opposed to serum amylase and lipase, results for 
which may require an hour to get back to the physician. 
 
 
3.  The urinary trypsinogen-2 test could  be used as a screening test 
for acute pancreatitis. 
 
4.  Modification of the cutoff point of this assay increases the 
specificity to the point where it can be used for diagnosis.  
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5.  Qualitative rapid urine trypsinogen-2 test strip is easy to perform. 
And hence it has  been shown to be a reliable and useful 
screening test for acute pancreatitis in daily practice 
[12-16], particularly in healthcare units lacking laboratory 
facilities. 
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PROFORMA 
      SL. NO: 
• NAME :       
• AGE /SEX:    
• IP NO:  
• ADDRESS WITH CONTACT NUMBER:  
 
• DATE OF ADMISSION:   
• DATE OF SURGERY:    
• DATE OF DISCHARGE: 
HISTORY OF PRESENTING ILLNESS:  
H/O abdomen pain  
                      Duration  
                      Nature of pain 
                      onset 
 Progression 
                      Radiating 
   Aggravating/relieving factors 
H/O vomiting  
Nature of vomitus 
                     No. of episodes 
   Associated with hemetemesis 
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   H/O Fever                   
                      Duration 
                      Nature 
                      Associated with chills & rigor: 
H/O  jaundice 
H/O abdomen distension 
H/O loss of appetite 
H/O loss of weight 
PAST HISTORY:  
DM/hypertension/asthma/TB/epilepsy/cardiac illness  
H/o similar episodes in the past, if any: 
H/o major illness/ hospital admissions, if any 
 
PERSONAL HISTORY: 
   Occupation 
Socio-economic status 
Alcohol 
Smoking 
Drug addiction 
FAMILY HISTORY: 
TREATMENT HISTORY: 
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CLINICAL EXAMINATION:  
General examination: Pallor                      Icterus 
                                     Pulse 
                            BP 
                                        Temperature 
                                        Respiratory Rate 
Systemic examination:        
CVS 
RS 
CNS 
Abdomen 
 
CLINICAL  DIAGNOSIS: 
 
 
INVESTIGATIONS:  
CBC:Hemoglobin 
        TC/DC: 
        ESR 
        PLATELET  
RFT:BLOOD UREA 
        SERUM CREATINE 
        SODIUM 
        POTASSIUM 
        RANDOM BLOOD SUGAR  
        CHLORIDE 
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LFT:TOTAL BILIRUBIN 
DIRECT BILIRUBIN 
INDIRECT BILIRUBIN 
SGOT  /SGPT 
ALKALINE PHOSPATASE  
TOTAL PROTEIN 
ALBUMIN  
X-RAY ABDOMEN 
X-RAY CHEST 
URINE TRYPSINOGEN-2  DIPSTICK:  
SERUM AMYLASE  
SERUM LIPASE 
USG ABDOMEN 
 
CECT ABDOMEN 
 
FINAL DIAGNOSIS: 
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sl_no name ip_no age sex
abd_
pain fever vomiting jaundice
abd_
distension alcohol gall_stone post_ercp hyper_tg amylase lipase usg ct
urine_
trypsinogen diagnosis
1 Jegan 38392 45 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
2 Anandhan 37332 42 Male 1 1 1 1 1 1 2 2 2 1 1 1 99 1 1
3 Dhanapal 34612 55 Male 1 1 1 2 1 1 2 2 2 1 1 1 99 1 1
4 Murugan 37377 40 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
5 Premkumar 26628 29 Male 1 1 1 1 1 1 2 2 2 2 2 2 1 2 1
6 Chellakannu 26301 34 Male 1 1 1 2 1 2 1 2 2 2 2 1 1 1 1
7 Rajendran 46982 46 Male 1 1 1 2 1 1 2 2 2 1 1 3 3 2 5
8 Rafiq 18441 50 Male 1 1 1 2 1 1 2 2 2 2 2 2 1 2 1
9 Prakash 23987 29 Male 1 1 1 1 1 1 2 2 2 2 2 2 1 2 1
10 Anandhan 6918 47 Male 1 1 1 1 1 1 2 2 2 1 1 1 99 1 1
11 Gopinath 26635 25 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
12 Arunprasath 39206 32 Male 1 1 1 2 1 2 1 2 2 1 1 1 1 1 1
13 Gopinath 22530 31 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
14 Prabu 22444 31 Male 1 2 2 2 2 1 2 2 2 2 2 1 99 2 1
15 Senthil pandi 6923 32 Male 1 1 1 2 2 1 2 2 2 2 2 4 99 2 2
16 Prabu 17439 21 Male 1 1 1 2 2 1 2 2 2 2 2 2 1 2 1
17 Arivazhagan 19405 46 Male 1 1 1 1 1 1 2 2 2 1 1 1 99 1 1
18 Kannan 26665 32 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
19 Pillayarsamy 37807 49 Male 1 2 2 2 2 1 2 2 2 2 2 1 99 2 1
20 Vijayakumar 36395 35 Male 1 2 1 2 2 2 2 2 2 2 2 99 99 2 3
21 Krishnan 37386 55 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
22 Murugan 39214 35 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
23 Rajam 39206 56 Male 1 1 1 2 2 1 2 2 2 1 1 4 3 2 7
24 Pushpavalli 39216 45 Female 1 1 1 2 1 2 2 2 2 2 2 3 3 1 5
25 Mariselvam 42570 24 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
26 Mohan 37469 50 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
27 Aruna 37419 30 Female 1 1 1 2 2 2 2 2 2 2 2 4 99 2 2
28 Munusamy 49947 42 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
29 Prakash 50684 25 Male 1 1 1 1 1 1 2 2 2 2 2 2 1 2 1
30 Aruldas 38435 60 Male 1 1 1 2 1 1 2 2 2 1 1 1 99 1 1
31 Malleswari 42262 24 Female 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
32 Wilson 40677 39 Male 1 2 1 2 2 1 2 2 2 2 2 99 99 2 3
MASTER CHART
87
33 Srinivasan 42845 30 Male 1 1 1 2 2 1 2 2 2 2 2 4 99 2 2
34 Ramesh 42942 38 Male 1 2 1 2 2 1 2 2 2 2 2 99 99 2 3
35 Syed ibrahim 42947 32 Male 1 1 1 2 2 2 2 2 2 2 2 4 99 2 2
36 Vijayakumar 34459 40 Male 1 2 1 2 2 1 2 2 2 2 2 99 99 2 3
37 Elumalai 34520 47 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
38 Manimegalai 34781 49 Female 1 1 1 1 2 2 1 2 2 2 2 3 3 2 6
39 Kathiresan 33291 42 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
40 Raju 33413 40 Male 1 2 1 2 2 1 2 2 2 2 2 99 99 2 3
41 Pattamal 30611 53 Female 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
42 Jayaraman 33444 27 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
43 Nagarajan 32075 57 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
44 Palani 32520 32 Male 1 2 2 2 2 1 2 2 2 2 2 1 99 2 1
45 Baskar 28928 48 Male 1 1 1 2 1 1 2 2 2 1 1 1 99 1 1
46 Gayathri 30619 22 Female 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
47 Nagaboosanam 28937 38 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
48 Ayyappan 29188 27 Male 1 1 1 2 1 1 2 2 2 1 1 1 99 1 1
49 Sivasankari 29136 34 Female 1 2 1 2 2 2 2 2 2 2 2 99 99 2 3
50 Premkumar 26628 29 Male 1 1 1 1 1 1 2 2 2 2 2 2 1 2 1
51 Vincent 26849 28 Male 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
52 Sivaranjani 26682 60 Female 1 1 2 1 1 2 2 2 2 2 2 3 3 2 8
53 Kumar 25379 46 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
54 Babu 25328 30 Male 1 1 1 2 1 2 2 2 1 1 1 1 99 1 1
55 Santhi 24611 32 Female 1 1 1 2 1 2 2 2 2 1 1 4 3 1 7
56 Ramamoorthy 24700 48 Male 1 1 1 1 1 1 2 2 2 2 2 3 3 2 5
57 Selvakumar 22840 30 Male 1 1 1 2 2 1 2 2 2 2 2 3 99 2 2
58 Subramani 22619 56 Male 1 1 2 2 1 1 2 2 2 2 2 3 3 2 8
59 Govindhammal 40173 27 Female 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
60 Rajendran 22757 50 Male 1 1 2 1 1 1 2 2 2 1 1 3 3 2 6
61 anandhi 21681 38 Female 1 1 1 1 1 2 1 2 2 2 2 1 1 1 1
62 Ramalingam 21240 45 Male 1 1 1 2 2 1 2 2 2 2 2 99 99 2 4
63 Jayakumar 49951 80 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
64 Vasudevan 7827 48 Male 1 1 1 1 2 2 1 2 2 2 2 3 3 2 6
65 Munusamy 34601 60 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
66 Shanmugam 35947 47 Male 1 1 1 2 1 1 2 2 2 2 2 3 3 2 5
67 Udayakumar 34982 34 Male 1 2 1 2 2 2 2 2 2 2 2 99 99 2 3
68 Eswari 17445 37 Female 1 2 1 2 2 2 2 2 2 2 2 99 99 2 3
69 Kumar 17447 24 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
88
70 Suganthi 28542 27 Female 1 1 1 2 1 2 2 2 1 2 2 2 1 1 1
71 Nandha 433112 55 Male 1 2 2 2 2 1 2 2 2 1 1 1 99 1 1
72 Vasanth 45186 23 Male 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
73 Veeraiah 38112 42 Male 1 1 1 2 2 2 2 2 2 2 2 99 99 2 4
74 Loganathan 43336 50 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
75 Amsa 2461 52 Female 1 1 1 1 1 2 1 2 2 2 2 1 1 1 1
76 Ragaramya 3382 36 Female 1 2 1 2 2 2 2 2 2 2 2 99 99 2 3
77 Sengootuvan 33501 45 Male 1 1 2 2 2 1 2 2 2 2 2 99 99 2 4
78 Krishnamoorthy 51474 45 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
79 Anandhan 26918 47 Male 1 1 1 1 1 2 1 2 2 1 1 1 1 1 1
80 Pillaiyarsamy 37807 49 Male 1 2 2 2 2 1 2 2 2 2 2 1 99 2 1
81 Arivazhagan 32076 46 Male 1 1 1 1 1 1 2 2 2 1 1 1 99 1 1
82 Suresh 24123 24 Male 1 1 1 2 2 2 2 2 2 2 2 3 99 2 2
83 Nageswara rao 64734 25 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
84 Arun 31829 45 Male 1 1 1 2 1 2 2 1 2 1 1 1 1 1 1
85 Bagiyanathan 28043 26 Male 1 1 1 2 1 1 2 2 2 1 1 1 99 1 1
86 Abdulhameed 28086 72 Male 1 1 1 1 1 1 2 2 2 1 1 1 99 1 1
87 Gani 29630 45 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
88 Sivaraman 30475 50 Male 1 1 1 2 2 1 2 2 2 2 2 4 3 1 7
89 Naseer hussain 29624 45 Male 1 2 2 2 2 1 2 2 2 1 1 1 99 2 1
90 Rajendran 34711 45 Male 1 1 1 2 2 2 2 2 2 2 2 99 99 2 4
91 Rangaraj 35579 40 Male 1 2 1 2 2 1 2 2 2 2 2 99 99 2 3
92 Murugammal 36497 30 Female 1 1 1 2 2 2 2 2 2 2 2 4 99 2 2
93 Palani 36509 37 Male 1 2 2 2 2 1 2 2 2 2 2 1 99 2 1
94 Dilly 35639 60 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
95 Mabu basha 35685 45 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
96 Ekambaram 38263 50 Male 1 2 1 2 1 1 2 2 2 1 1 1 99 1 1
97 Kamaleswaran 51612 32 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
98 Radhakrishnan 51658 55 Male 1 1 1 2 1 1 2 2 2 2 2 2 1 2 1
99 Rajesh 33762 45 Male 1 1 1 2 2 2 2 2 2 2 2 99 99 2 4
100 Jeeva 34448 41 Male 1 2 1 2 2 1 2 2 2 1 1 1 99 1 1
89
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GßÝøh¯ ©¸zxÁ AÔUøPPøÍ £õº¨£uØ@Põ AÀ»x 
E£@¯õQUP@Áõ Gß AÝ©v @uøÁ°Àø» GÚ AÔ¢x 
öPõÒQ@Óß. GßøÚ¨ £ØÔ¯ uPÁÀPÒ µP]¯©õP £õxPõUP¨£k® 
Gß£øu AÔ@Áß. 
 C¢u B#Âß ‰»® QøhUS® uPÁÀPøÍ²®, £›@ŒõuøÚ 
•iÄPøÍ²®, B#ÁõÍº AÁº Â¸¨£zvØ@PØ£ GÆÂu©õP¨ 
£¯ß£kzvU öPõÒÍÄ®, Aøu ¤µ”›UPÄ® Gß •Ê©Úxhß 
Œ®©vUQ@Óß. 
 C¢u B#ÂÀ £[S öPõÒÍ J¨¦U öPõÒQ@Óß. GÚUSU 
öPõkUP¨£mh AÔÄøµPÎß£i |h¢x öPõÒÁxhß 
B#ÁõÍ¸US Esø©²hß C¸¨@£ß GßÖ EÖv¯ÎUQ@Óß. 
Gß EhÀ |»® £õvUP¨£mhõ@»õ AÀ»x Gvº£õµõu ÁÇUPzvØS 
©õÓõÚ @|õ#USÔ öuß£mhõ@»õ Eh@Ú Aøu öu›Â¨@£ß GÚ 
EÖv TÖQ@Óß. 
 C¢u B#ÂÀ £[S öPõÒÍÁuØS®, ©ØÖ® AøÚzx¨ 
£›@ŒõuøÚPøÍ²® ]QaøŒPøÍ²® @©ØöPõÒÍ •Ê©Úxhß 
Œ®©vUQ@Óß. 
C¨£iUS, 
 
B#ÁõÍº øPö¯õ¨£®    @|õ¯õÎ°ß øPö¯õ¨£® 
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wÂµ Pøn¯ AÇØ]°À ]Ö}º i›¨]@|õáß &2 
‰»® Â¯õv {ºn¯® öŒ#uÀ 
 
 
 
 
 
 
B#ÁõÍº  : hõUhº.|õ.Œ[Pµ |õµõ¯nß 
    •x{ø» £mh @©Ø£i¨¦ ©õnÁº. 
    AÖøÁ ]QaøŒ £mh£i¨¦ 
£[@PØ£õÍ›ß uPÁÀ £iÁ® 
 }[PÒ C¢u B#ÂÀ £[@PØP AøÇUP¨£kQÕºPÒ, C¢u B#ÂÀ 
£[@PØS® •ßÚº, Cuß @|õUPzøu²®, •øÓPøÍ²® CuÚõÀ 
HØ£hUTi¯ ¤ßÂøÍÄPÒ H@uøÚ²® }[PÒ AÔ¢xU öPõÒÍ 
B#ÁõÍº AÎUS® uPÁÀ ¤ßÁ¸©õÖ. 
 wÂµ Pøn¯ AÇØ]°À, Pøn¯® £õv¨£øh¢x Pøn¯ 
GßøŒ® Cµzu® ©ØÖ® ]Ö}›À öÁÎ¯õS®. CvÀ i›¨]@|õáß&2 
GßÝ® GßøŒ® EÒÍx. 
 wÂµ Pøn¯ AÇØ]°À Á°ÖÁ¼, Áõ¢v, Á°Ö Â›Ä ©ØÖ® 
ªß£SÎ Œ©a^›ßø© EshõS®, @©¾® Pøn |]Ä HØ£mhõÀ, 
AuØS AÖøÁ ]QaøŒ @uøÁ £h Áõ#¨¦ EÒÍx. 
 @©¾® Pøn¯ AÇØ]°À ]Ö}µP® £õv¨£øh¯ Áõ#¨¦ÒÍx. 
ªß£SÎ Œ®a^›ßø©¯õÀ ‰ø», Cu¯® ©ØÖ® ©ØÓ EÖ¨¦PÒ 
£õv¨£øh¯ Áõ#¨¦ÒÍx. @©¾® wÂµ Pøn¯ AÇØ]°À, wÂµ 
]QaøŒ ¤›ÂÀ AÝ©vUP¨£mk øÁzv¯® öŒ#¯Ä® @uøÁ£k®. 
 wÂµ Pøn¯ AÇØ]°À i›¨]@|õáß &2 GßÝ® GßøŒ® 
Cµzu® ©ØÖ® ]Ö}›À P»US® Gß£øu²®, CuøÚ ÂøµÂÀ 
PshÔ¢x ]UPÀ CÀ»õ©À ]QaøŒ AÎUP•i²®. 
 uõ[PÒ C¢u B#ÂØS Œ®©u® öu›ÂUS® £mŒzvÀ C¢u 
£iÁzøu •Êø©¯õP £izx £õºzx •Ê©Úxhß øPö¯õ¨£ªk©õÖ 
@PmkUöPõÒQ@Óß. @©¾® C¢u B#ÂÚõÀ u[PÒ Eh¾U@Põ, 
©ÚxU@Põ G¢uÂu EøÍaŒÀ HØ£hõx GßÖ® EÖv¯ÎUQ@Óß. 
 C¢u B#Âß •iÄPÒ ©¸zxÁU Põµn[PÐUPõPÄ®, ©¸zxÁU 
PÀÂUPõPÄ® £¯ß£kzu¨£k®. C¢u B#Ä £ØÔ¯ Œ¢@uP[PÐUS 
E›¯ •øÓ°À ÂÍUP©ÎUP¨£k®. u[PøÍ¨ £ØÔ¯ uPÁÀPÒ 
µP]¯©õP £õxPõUP¨£k®. 
 C¢u B#Â¼¸¢x G¨ö£õÊx @Ásk©õÚõ¾®, uõ[PÒ GÆÂu 
•ßÚÔÂ¨¤ßÔ²®, GÆÂu ŒmhU ]UPÀ CßÔ²®, Â»QU 
öPõÒÍ»õ®. 
 C¢u B#ÂÀ £[@PØS©õÖ @PmkU öPõÒQ@Óß. 
|ßÔ 
 
 
B#ÁõÍº øPö¯õ¨£®    @|õ¯õÎ°ß øPö¯õ¨£® 
hõUhº.|õ.Œ[Pµ |õµõ¯nß   ö£¯º : 
